Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robb E Wilentz

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Methods in Molecular Medicine|November 16, 2004
Identification and analysis of precursors to invasive pancreatic cancerRalph H Hruban, Robb E Wilentz, Anirban Maitra
Methods in Molecular Medicine|November 16, 2004
Immunohistochemistry and in situ hybridization in pancreatic neoplasiaRobb E Wilentz, Ayman Rahman, Pedram Argani, et al.
International Journal of Gastrointestinal Cancer|October 18, 2005
Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformationDengfeng Cao, Robb E Wilentz, James L Abbruzzese, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2002
Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progressionWalter M Klein, Ralph H Hruban, Andres J P Klein-Szanto, et al.
The Annals of Thoracic Surgery|April 10, 2003
Atheroembolism in cardiac surgeryJohn R Doty, Robb E Wilentz, Jorge D Salazar, et al.
Pathology|January 31, 2003
Premalignant conditions of the pancreasPauline de la M Hall, Robb E Wilentz, Willouw de Klerk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2002
Hepatocellular carcinomas show abnormal expression of fibronectin proteinMichael Torbenson, Jianzhou Wang, Michael Choti, et al.
Pancreas|February 17, 2005
RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epitheliumFikret Sahin, Wanglong Qiu, Robb E Wilentz, et al.
Cancer Biology & Therapy|July 25, 2003
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignanciesElizabeth Montgomery, Robb E Wilentz, Pedram Argani, et al.
American Journal of Clinical Pathology|March 15, 2005
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatmentDonna E Hansel, Raheela Ashfaq, Ayman Rahman, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Methods in Molecular Medicine|November 16, 2004
Identification and analysis of precursors to invasive pancreatic cancerRalph H Hruban, Robb E Wilentz, Anirban Maitra
Methods in Molecular Medicine|November 16, 2004
Immunohistochemistry and in situ hybridization in pancreatic neoplasiaRobb E Wilentz, Ayman Rahman, Pedram Argani, et al.
International Journal of Gastrointestinal Cancer|October 18, 2005
Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformationDengfeng Cao, Robb E Wilentz, James L Abbruzzese, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2002
Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progressionWalter M Klein, Ralph H Hruban, Andres J P Klein-Szanto, et al.
The Annals of Thoracic Surgery|April 10, 2003
Atheroembolism in cardiac surgeryJohn R Doty, Robb E Wilentz, Jorge D Salazar, et al.
Pathology|January 31, 2003
Premalignant conditions of the pancreasPauline de la M Hall, Robb E Wilentz, Willouw de Klerk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2002
Hepatocellular carcinomas show abnormal expression of fibronectin proteinMichael Torbenson, Jianzhou Wang, Michael Choti, et al.
Pancreas|February 17, 2005
RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epitheliumFikret Sahin, Wanglong Qiu, Robb E Wilentz, et al.
Cancer Biology & Therapy|July 25, 2003
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignanciesElizabeth Montgomery, Robb E Wilentz, Pedram Argani, et al.
American Journal of Clinical Pathology|March 15, 2005
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatmentDonna E Hansel, Raheela Ashfaq, Ayman Rahman, et al.
Pageof 3